Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010, Article ID 453892, 11 pages
http://dx.doi.org/10.1155/2010/453892
Review Article

Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan

Received 28 September 2009; Accepted 13 November 2009

Academic Editor: Giamila Fantuzzi

Copyright © 2010 Hideaki Kaneto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. W. Baynes and S. R. Thorpe, “Role of oxidative stress in diabetic complications: a new perspective on an old paradigm,” Diabetes, vol. 48, no. 1, pp. 1–9, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Dandona, K. Thusu, S. Cook et al., “Oxidative damage to DNA in diabetes mellitus,” The Lancet, vol. 347, no. 8999, pp. 444–445, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Sakurai and S. Tsuchiya, “Superoxide production from nonenzymatically glycated protein,” FEBS Letters, vol. 236, no. 2, pp. 406–410, 1988. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, no. 6865, pp. 813–820, 2001. View at Google Scholar
  5. D. Harrison, K. K. Griendling, U. Landmesser, B. Hornig, and H. Drexler, “Role of oxidative stress in atherosclerosis,” The American Journal of Cardiology, vol. 91, no. 3, pp. 7A–11A, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. H. K. M. Mohazzab, P. M. Kaminski, and M. S. Wolin, “NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium,” American Journal of Physiology, vol. 266, no. 6, pp. H2568–H2572, 1994. View at Google Scholar · View at Scopus
  7. G. C. Weir, D. R. Laybutt, H. Kaneto, S. Bonner-Weir, and A. Sharma, “β-cell adaptation and decompensation during the progression of diabetes,” Diabetes, vol. 50, supplement 1, pp. S154–S159, 2001. View at Google Scholar · View at Scopus
  8. M. Prentki and C. J. Nolan, “Islet β cell failure in type 2 diabetes,” The Journal of Clinical Investigation, vol. 116, no. 7, pp. 1802–1812, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. V. Poitout, L. K. Olson, and R. P. Robertson, “Chronic exposure of βTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator,” The Journal of Clinical Investigation, vol. 97, no. 4, pp. 1041–1046, 1996. View at Google Scholar · View at Scopus
  10. V. Poitout and R. P. Robertson, “Minireview: secondary β-cell failure in type 2 diabetes—a convergence of glucotoxicity and lipotoxicity,” Endocrinology, vol. 143, no. 2, pp. 339–342, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Sharma, D. Fusco-DeMane, E. Henderson, S. Efrat, and R. Stein, “The role of the insulin control element and RIPE3b1 activators in glucose-stimulated transcription of the insulin gene,” Molecular Endocrinology, vol. 9, no. 11, pp. 1468–1476, 1995. View at Google Scholar · View at Scopus
  12. A. Moran, H.-J. Zhang, L. K. Olson, J. S. Harmon, V. Poitout, and R. P. Robertson, “Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line, HIT-T15,” The Journal of Clinical Investigation, vol. 99, no. 3, pp. 534–539, 1997. View at Google Scholar · View at Scopus
  13. J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, “Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction?” Diabetes, vol. 52, pp. 1–8, 2003. View at Google Scholar
  14. S.-I. Gorogawa, Y. Kajimoto, Y. Umayahara et al., “Probucol preserves pancreatic β-cell function through reduction of oxidative stress in type 2 diabetes,” Diabetes Research and Clinical Practice, vol. 57, no. 1, pp. 1–10, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. J. S. Harmon, R. Stein, and R. P. Robertson, “Oxidative stress-mediated, post-translational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells,” The Journal of Biological Chemistry, vol. 280, no. 12, pp. 11107–11113, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. Y. Ihara, S. Toyokuni, K. Uchida et al., “Hyperglycemia causes oxidative stress in pancreatic β-cells of GK rats, a model of type 2 diabetes,” Diabetes, vol. 48, no. 4, pp. 927–932, 1999. View at Google Scholar · View at Scopus
  17. Y. Kajimoto, T. Matsuoka, H. Kaneto et al., “Induction of glycation suppresses glucokinase gene expression in HIT-T15 cells,” Diabetologia, vol. 42, no. 12, pp. 1417–1424, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Maechler, L. Jornot, and C. B. Wollheim, “Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells,” The Journal of Biological Chemistry, vol. 274, no. 39, pp. 27905–27913, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Kaneto, Y. Kajimoto, J. Miyagawa et al., “Beneficial effects of antioxidants in diabetes: possible protection of pancreatic β-cells against glucose toxicity,” Diabetes, vol. 48, no. 12, pp. 2398–2406, 1999. View at Google Scholar · View at Scopus
  20. H. Kaneto, G. Xu, K.-H. Song et al., “Activation of the hexosamine pathway leads to deterioration of pancreatic β-cell function through the induction of oxidative stress,” The Journal of Biological Chemistry, vol. 276, no. 33, pp. 31099–31104, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. H. Kaneto, T.-A. Matsuoka, Y. Nakatani et al., “Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes,” Journal of Molecular Medicine, vol. 83, no. 6, pp. 429–439, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. T.-A. Matsuoka, Y. Kajimoto, H. Watada et al., “Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells,” The Journal of Clinical Investigation, vol. 99, no. 1, pp. 144–150, 1997. View at Google Scholar · View at Scopus
  23. R. P. Robertson, J. Harmon, P. O. Tran, Y. Tanaka, and H. Takahashi, “Glucose toxicity in β-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection,” Diabetes, vol. 52, no. 3, pp. 581–587, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. A. P. Robertson, “Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes,” The Journal of Biological Chemistry, vol. 279, no. 41, pp. 42351–42354, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. Y. Tanaka, C. E. Gleason, P. O. T. Tran, J. S. Harmon, and R. P. Robertson, “Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, pp. 10857–10862, 1999. View at Google Scholar
  26. Y. Tanaka, P. O. T. Tran, J. Harmon, and R. P. Robertson, “A role of glutathione peroxidase in protecting pancreatic β cells against oxidative stress in a model of glucose toxicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, pp. 12363–12368, 2002. View at Google Scholar
  27. K. Sakai, K. Matsumoto, T. Nishikawa et al., “Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic β-cells,” Biochemical and Biophysical Research Communications, vol. 300, no. 1, pp. 216–222, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Kaneto, J. Fujii, T. Myint et al., “Reducing sugars trigger oxidative modification and apoptosis in pancreatic β-cells by provoking oxidative stress through the glycation reaction,” Biochemical Journal, vol. 320, no. 3, pp. 855–863, 1996. View at Google Scholar · View at Scopus
  29. H. Ohlsson, K. Karlsson, and T. Edlund, “IPF1, a homeodomain-containing transactivator of the insulin gene,” EMBO Journal, vol. 12, no. 11, pp. 4251–4259, 1993. View at Google Scholar · View at Scopus
  30. J. Leonard, B. Peers, T. Johnson, K. Ferreri, S. Lee, and M. R. Montminy, “Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells,” Molecular Endocrinology, vol. 7, no. 10, pp. 1275–1283, 1993. View at Publisher · View at Google Scholar · View at Scopus
  31. C. P. Miller, R. E. McGehee Jr., and J. F. Habener, “IDX-1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene,” EMBO Journal, vol. 13, no. 5, pp. 1145–1156, 1994. View at Google Scholar · View at Scopus
  32. J. Jonsson, L. Carlsson, T. Edlund, and H. Edlund, “Insulin-promoter-factor 1 is required for pancreas development in mice,” Nature, vol. 371, no. 6498, pp. 606–609, 1994. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. D. A. Stoffers, N. T. Zinkin, V. Stanojevic, W. L. Clarke, and J. F. Habener, “Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence,” Nature Genetics, vol. 15, no. 1, pp. 106–110, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. U. Ahlgren, J. Jonsson, L. Jonsson, K. Simu, and H. Edlund, “β-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetes,” Genes and Development, vol. 12, no. 12, pp. 1763–1768, 1998. View at Google Scholar · View at Scopus
  35. S. Ferber, A. Halkin, H. Cohen et al., “Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia,” Nature Medicine, vol. 6, no. 5, pp. 568–572, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. A. M. Holland, M. A. Hale, H. Kagami, R. E. Hammer, and R. J. MacDonald, “Experimental control of pancreatic development and maintenance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 19, pp. 12236–12241, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. H. Noguchi, H. Kaneto, G. C. Weir, and S. Bonner-Weir, “PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells,” Diabetes, vol. 52, no. 7, pp. 1732–1737, 2003. View at Google Scholar · View at Scopus
  38. S. Miyazaki, E. Yamato, and J.-I. Miyazaki, “Regulated expression of PDX-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells,” Diabetes, vol. 53, no. 4, pp. 1030–1037, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Kaneto, Y. Nakatani, T. Miyatsuka et al., “PDX-1/VP16 fusion protein, together with NeuroD or Ngn3, markedly induces insulin gene transcription and ameliorates glucose tolerance,” Diabetes, vol. 54, no. 4, pp. 1009–1022, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Kaneto, T. Miyatsuka, T. Shiraiwa et al., “Crucial role of PDX-1 in pancreas development, β-cell differentiation, and induction of surrogate β-cells,” Current Medicinal Chemistry, vol. 14, no. 16, pp. 1745–1752, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Kaneto, T. Miyatsuka, D. Kawamori et al., “PDX-1 and MafA play a crucial role in pancreatic β-cell differentiation and maintenance of mature β-cell function,” Endocrine Journal, vol. 55, pp. 235–252, 2008. View at Google Scholar
  42. M. Olbrot, J. Rud, L. G. Moss, and A. Sharma, “Identification of β-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 10, pp. 6737–6742, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. K. Kataoka, S.-I. Han, S. Shioda, M. Hirai, M. Nishizawa, and H. Handa, “MafA is a glucose-regulated and pancreatic β-cell-specific transcriptional activator for the insulin gene,” The Journal of Biological Chemistry, vol. 277, no. 51, pp. 49903–49910, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. T.-A. Matsuoka, L. Zhao, I. Artner et al., “Members of the large Maf transcription family regulate insulin gene transcription in islet β cells,” Molecular and Cellular Biology, vol. 23, no. 17, pp. 6049–6062, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. T.-A. Matsuoka, I. Artner, E. Henderson, A. Means, M. Sander, and R. Stein, “The MafA transcription factor appears to be responsible for tissue-specific expression of insulin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 2930–2933, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. H. Kaneto, T.-A. Matsuoka, Y. Nakatani et al., “A crucial role of MafA as a novel therapeutic target for diabetes,” The Journal of Biological Chemistry, vol. 280, no. 15, pp. 15047–15052, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. T.-A. Matsuoka, H. Kaneto, R. Stein et al., “MafA regulates expression of genes important to islet β-cell function,” Molecular Endocrinology, vol. 21, no. 11, pp. 2764–2774, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. S. Lenzen, J. Drinkgern, and M. Tiedge, “Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues,” Free Radical Biology and Medicine, vol. 20, no. 3, pp. 463–466, 1996. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Tiedge, S. Lortz, J. Drinkgern, and S. Lenzen, “Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells,” Diabetes, vol. 46, no. 11, pp. 1733–1742, 1997. View at Google Scholar · View at Scopus
  50. J. Shao, N. Iwashita, F. Ikeda et al., “Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on β-cell function and morphology in db/db mice,” Biochemical and Biophysical Research Communications, vol. 344, no. 4, pp. 1224–1233, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. M. Nakayama, T. Inoguchi, T. Sonta et al., “Increased expression of NAD(P)H oxidase in islets of animal models of type 2 diabetes and its improvement by an AT1 receptor antagonist,” Biochemical and Biophysical Research Communications, vol. 332, no. 4, pp. 927–933, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. C. Carlsson, L. A. H. Borg, and N. Welsh, “Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro,” Endocrinology, vol. 140, no. 8, pp. 3422–3428, 1999. View at Google Scholar · View at Scopus
  53. J. W. Joseph, V. Koshkin, M. C. Saleh et al., “Free fatty acid-induced β-cell defects are dependent on uncoupling protein 2 expression,” The Journal of Biological Chemistry, vol. 279, no. 49, pp. 51049–51056, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. X. Wang, H. Li, D. De Leo et al., “Gene and protein kinase expression profiling of reactive oxygen species-associated lipotoxicity in the pancreatic β-cell line MIN6,” Diabetes, vol. 53, pp. 129–140, 2004. View at Google Scholar
  55. A. I. Oprescu, G. Bikopoulos, A. Naassan et al., “Free fatty acid-induced reduction in glucose-stimulated insulin secretion: evidence for a role of oxidative stress in vitro and in vivo,” Diabetes, vol. 56, no. 12, pp. 2927–2937, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. G. Bikopoulos, A. da Silva Pimenta, S. C. Lee et al., “Ex vivo transcriptional profiling of human pancreatic islets following chronic exposure to monounsaturated fatty acids,” Journal of Endocrinology, vol. 196, no. 3, pp. 455–464, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. M. Shimabukuro, M. Ohneda, Y. Lee, and R. H. Unger, “Role of nitric oxide in obesity-induced β cell disease,” The Journal of Clinical Investigation, vol. 100, no. 2, pp. 290–295, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. H. Kaneto, J. Fujii, H. G. Seo et al., “Apoptotic cell death triggered by nitric oxide in pancreatic β-cells,” Diabetes, vol. 44, no. 7, pp. 733–738, 1995. View at Google Scholar · View at Scopus
  59. H. Kaneto, G. Xu, N. Fujii, S. Kim, S. Bonner-Weir, and G. C. Weir, “Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression,” The Journal of Biological Chemistry, vol. 277, no. 33, pp. 30010–30018, 2002. View at Google Scholar · View at Scopus
  60. D. Kawamori, Y. Kajimoto, H. Kaneto et al., “Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH2-terminal kinase,” Diabetes, vol. 52, no. 12, pp. 2896–2904, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Ogg, S. Paradis, S. Gottlieb et al., “The fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans,” Nature, vol. 389, no. 6654, pp. 994–999, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. D. Accili and K. C. Arden, “FoxOs at the crossroads of cellular metabolism, differentiation, and transformation,” Cell, vol. 117, no. 4, pp. 421–426, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Nakae, W. H. Biggs III, T. Kitamura et al., “Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1,” Nature Genetics, vol. 32, no. 2, pp. 245–253, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. W. H. Biggs III, J. Meisenhelder, T. Hunter, W. K. Cavenee, and K. C. Arden, “Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 13, pp. 7421–7426, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Kitamura, J. Nakae, Y. Kitamura et al., “The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth,” The Journal of Clinical Investigation, vol. 110, no. 12, pp. 1839–1847, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. D. Kawamori, H. Kaneto, Y. Nakatani et al., “The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation,” The Journal of Biological Chemistry, vol. 281, no. 2, pp. 1091–1098, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. M. K. Lehtinen, Z. Yuan, P. R. Boag et al., “A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span,” Cell, vol. 125, pp. 987–1001, 2006. View at Google Scholar
  68. C. Bonny, P. Nicod, and G. Waeber, “IB1, a JIP-1-related nuclear protein present in insulin-secreting cells,” The Journal of Biological Chemistry, vol. 273, no. 4, pp. 1843–1846, 1998. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Dickens, J. S. Rogers, J. Cavanagh et al., “A cytoplasmic inhibitor of the JNK signal transduction pathway,” Science, vol. 277, no. 5326, pp. 693–696, 1997. View at Publisher · View at Google Scholar · View at Scopus
  70. G. Waeber, J. Delplanque, C. Bonny et al., “The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes,” Nature Genetics, vol. 24, no. 3, pp. 291–295, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. G. I. Shulman, “Cellular mechanisms of insulin resistance,” The Journal of Clinical Investigation, vol. 106, no. 2, pp. 171–176, 2000. View at Google Scholar · View at Scopus
  72. A. R. Saltiel and C. R. Kahn, “Insulin signalling and the regulation of glucose and lipid metabolism,” Nature, vol. 414, no. 6865, pp. 799–806, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. T. Kadowaki, “Insights into insulin resistance and type 2 diabetes from knockout mouse models,” The Journal of Clinical Investigation, vol. 106, no. 4, pp. 459–465, 2000. View at Google Scholar · View at Scopus
  74. B. B. Kahn and J. S. Flier, “Obesity and insulin resistance,” The Journal of Clinical Investigation, vol. 106, no. 4, pp. 473–481, 2000. View at Google Scholar · View at Scopus
  75. J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, “Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes,” Endocrine Reviews, vol. 23, no. 5, pp. 599–622, 2002. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Rudich, A. Tlrosh, R. Potashnik, R. Hemi, H. Kanety, and N. Bashan, “Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes,” Diabetes, vol. 47, no. 10, pp. 1562–1569, 1998. View at Publisher · View at Google Scholar · View at Scopus
  77. A. Tirosh, R. Potashnik, N. Bashan, and A. Rudich, “Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes: a putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation,” The Journal of Biological Chemistry, vol. 274, no. 15, pp. 10595–10602, 1999. View at Publisher · View at Google Scholar · View at Scopus
  78. C. A. Haber, T. K. T. Lam, Z. Yu et al., “N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress,” American Journal of Physiology, vol. 285, no. 4, pp. E744–E753, 2003. View at Google Scholar · View at Scopus
  79. S. Jacob, P. Ruus, R. Hermann et al., “Oral administration of rac-α-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial,” Free Radical Biology and Medicine, vol. 27, no. 3-4, pp. 309–314, 1999. View at Publisher · View at Google Scholar · View at Scopus
  80. T. Konrad, P. Vicini, K. Kusterer et al., “α-lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes,” Diabetes Care, vol. 22, no. 2, pp. 280–287, 1999. View at Publisher · View at Google Scholar · View at Scopus
  81. G. S. Hotamisligil, “Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes,” Diabetes, vol. 54, supplement 2, pp. S73–S78, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. K. E. Wellen and G. S. Hotamisligil, “Inflammation, stress, and diabetes,” The Journal of Clinical Investigation, vol. 115, no. 5, pp. 1111–1119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Hirosumi, G. Tuncman, L. Chang et al., “A central role for JNK in obesity and insulin resistance,” Nature, vol. 420, no. 6913, pp. 333–336, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. Y. Nakatani, H. Kaneto, D. Kawamori et al., “Modulation of the JNK pathway in liver affects insulin resistance status,” The Journal of Biological Chemistry, vol. 279, no. 44, pp. 45803–45809, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. V. Aguirre, T. Uchida, L. Yenush, R. Davis, and M. F. White, “The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307,” The Journal of Biological Chemistry, vol. 275, no. 12, pp. 9047–9054, 2000. View at Publisher · View at Google Scholar · View at Scopus
  86. G. Elliott and P. O'Hare, “Intercellular trafficking and protein delivery by a herpesvirus structural protein,” Cell, vol. 88, no. 2, pp. 223–233, 1997. View at Publisher · View at Google Scholar · View at Scopus
  87. A. D. Frankel and C. O. Pabo, “Cellular uptake of the tat protein from human immunodeficiency virus,” Cell, vol. 55, no. 6, pp. 1189–1193, 1988. View at Google Scholar · View at Scopus
  88. H. Nagahara, A. M. Vocero-Akbani, E. L. Snyder et al., “Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p-27Kip1 induces cell migration,” Nature Medicine, vol. 4, no. 12, pp. 1449–1452, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  89. H. Noguchi, M. Matsushita, T. Okitsu et al., “A new cell-permeable peptide allows successful allogeneic islet transplantation in mice,” Nature Medicine, vol. 10, no. 3, pp. 305–309, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. J. B. Rothbard, S. Garlington, Q. Lin et al., “Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation,” Nature Medicine, vol. 6, no. 11, pp. 1253–1257, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  91. S. R. Schwarze, A. Ho, A. Vocero-Akbani, and S. F. Dowdy, “In vivo protein transduction: delivery of a biologically active protein into the mouse,” Science, vol. 285, no. 5433, pp. 1569–1572, 1999. View at Publisher · View at Google Scholar · View at Scopus
  92. C. Bonny, A. Oberson, S. Negri, C. Sause, and D. F. Schorderet, “Cell-permeable peptide inhibitors of JNK: novel blockers of β-cell death,” Diabetes, vol. 50, pp. 77–82, 2001. View at Google Scholar
  93. H. Kaneto, Y. Nakatani, T. Miyatsuka et al., “Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide,” Nature Medicine, vol. 10, no. 10, pp. 1128–1132, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. F. Urano, X. Wang, A. Bertolotti et al., “Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1,” Science, vol. 287, no. 5453, pp. 664–666, 2000. View at Publisher · View at Google Scholar · View at Scopus
  95. U. Ozcan, Q. Cao, E. Yilmaz et al., “Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes,” Science, vol. 306, no. 5695, pp. 457–461, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. K. E. Wellen and G. S. Hotamisligil, “Inflammation, stress, and diabetes,” The Journal of Clinical Investigation, vol. 115, no. 5, pp. 1111–1119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. M. Yuan, N. Konstantopoulos, J. Lee et al., “Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ,” Science, vol. 293, no. 5535, pp. 1673–1677, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. D. Cai, M. Yuan, D. F. Frantz et al., “Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB,” Nature Medicine, vol. 11, no. 2, pp. 183–190, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. M. C. Arkan, A. L. Hevener, F. R. Greten et al., “IKK-β links inflammation to obesity-induced insulin resistance,” Nature Medicine, vol. 11, no. 2, pp. 191–198, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  100. Y. Tamura, T. Ogihara, T. Uchida et al., “Amelioration of glucose tolerance by hepatic inhibition of nuclear factor κB in db/db mice,” Diabetologia, vol. 50, no. 1, pp. 131–141, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  101. R. Kawamori, Y. Yamasaki, H. Matsushima et al., “Prevalence of carotid atherosclerosis in diabetic patients: ultrasound high-resolution B-mode imaging on carotid arteries,” Diabetes Care, vol. 15, no. 10, pp. 1290–1294, 1992. View at Google Scholar · View at Scopus
  102. Y. Yamasaki, R. Kawamori, H. Matsushima et al., “Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging,” Diabetes, vol. 43, no. 5, pp. 634–639, 1994. View at Google Scholar · View at Scopus
  103. Y. Yamasaki, R. Kawamori, H. Matsushima et al., “Asymptomatic hyperglycaemia is associated with increased intimal plus medial thickness of the carotid artery,” Diabetologia, vol. 38, no. 5, pp. 585–591, 1995. View at Publisher · View at Google Scholar · View at Scopus
  104. K. Aral, Y. Yamasaki, Y. Kajimoto et al., “Association of methylenetetrahydrofolate reductase gene polymorphism with carotid arterial wall thickening and myocardial infarction risk in NIDDM,” Diabetes, vol. 46, no. 12, pp. 2102–2104, 1997. View at Google Scholar · View at Scopus
  105. R. Hayaishi-Okano, Y. Yamasaki, Y. Kajimoto et al., “Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes,” Diabetes Care, vol. 26, no. 2, pp. 458–463, 2003. View at Publisher · View at Google Scholar · View at Scopus
  106. Y. Yamasaki, N. Katakami, K. Sakamoto et al., “Combination of multiple genetic risk factors was synergistically associated with carotid atherosclerosis in subjects with type 2 diabetes,” Diabetes Care, vol. 29, pp. 2445–2451, 2006. View at Google Scholar
  107. N. Katakami, Y. Yamasaki, R. Hayaishi-Okano et al., “Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes,” Diabetologia, vol. 47, no. 11, pp. 1906–1913, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  108. Y. Yamasaki, N. Katakami, R. Hayaishi-Okano et al., “α-glucosidase inhibitor reduces the progression of carotid intima-media thickness,” Diabetes Research and Clinical Practice, vol. 67, no. 3, pp. 204–210, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  109. H. Yokoyama, N. Katakami, and Y. Yamasaki, “Recent advances of intervention to inhibit progression of carotid intima-media thickness in patients with type 2 diabetes mellitus,” Stroke, vol. 37, no. 9, pp. 2420–2427, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  110. M. Ushio-Fukai, A. M. Zafari, T. Fukui, N. Ishizaka, and K. K. Griendling, “p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells,” The Journal of Biological Chemistry, vol. 271, no. 38, pp. 23317–23321, 1996. View at Publisher · View at Google Scholar
  111. U. Hink, H. Li, H. Mollnau et al., “Mechanisms underlying endothelial dysfunction in diabetes mellitus,” Circulation Research, vol. 88, no. 2, pp. E14–E22, 2001. View at Google Scholar
  112. T. Inoguchi, P. Li, F. Umeda et al., “High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C—dependent activation of NAD(P)H oxidase in cultured vascular cells,” Diabetes, vol. 49, no. 11, pp. 1939–1945, 2000. View at Publisher · View at Google Scholar
  113. T. J. Guzik, S. Mussa, D. Gastaldi et al., “Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase,” Circulation, vol. 105, no. 14, pp. 1656–1662, 2002. View at Publisher · View at Google Scholar
  114. Y. K. Kim, M.-S. Lee, S. M. Son et al., “Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes,” Diabetes, vol. 51, no. 2, pp. 522–527, 2002. View at Google Scholar
  115. P. A. Barry-Lane, C. Patterson, M. van der Merwe et al., “p47phox is required for atherosclerotic lesion progression in ApoE/ mice,” The Journal of Clinical Investigation, vol. 108, no. 10, pp. 1513–1522, 2001. View at Publisher · View at Google Scholar
  116. H. Azumi, N. Inoue, Y. Ohashi et al., “Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 11, pp. 1838–1844, 2002. View at Publisher · View at Google Scholar
  117. A. Fortuno, G. San Jose, M. U. Moreno, O. Beloqui, J. Diez, and G. Zalba, “Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome,” Diabetes, vol. 55, pp. 209–215, 2006. View at Google Scholar
  118. N. Katakami, K. Sakamoto, H. Kaneto et al., “Combined effect of oxidative stress-related gene polymorphisms on atherosclerosis,” Biochemical and Biophysical Research Communications, vol. 379, pp. 861–865, 2009. View at Google Scholar
  119. N. Katakami, M. Saito, H. Kaneto et al., “Combined effect of oxidative stress-related gene polymorphisms on the progression of carotid atherosclerosis in Japanese type 2 diabetes,” Atherosclerosis, vol. 207, no. 1, pp. 29–31, 2009. View at Publisher · View at Google Scholar · View at PubMed
  120. N. Katakami, K. Sakamoto, H. Kaneto et al., “Cumulative effect of oxidative stress-related gene polymorphisms on myocardial infarction in type 2 diabetes,” Diabetes Care, vol. 32, no. 5, article e55, 2009. View at Google Scholar
  121. H. Cai and D. G. Harrison, “Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress,” Circulation Research, vol. 87, no. 10, pp. 840–844, 2000. View at Google Scholar
  122. J. L. Mehta, N. Rasouli, A. K. Sinha, and B. Molavi, “Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 5-6, pp. 794–803, 2006. View at Publisher · View at Google Scholar · View at PubMed
  123. U. Chakravarthy, R. G. Hayes, A. W. Stitt, E. McAuley, and D. B. Archer, “Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products,” Diabetes, vol. 47, no. 6, pp. 945–952, 1998. View at Publisher · View at Google Scholar
  124. N. R. Madamanchi, A. Vendrov, and M. S. Runge, “Oxidative stress and vascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 1, pp. 29–38, 2005. View at Publisher · View at Google Scholar · View at PubMed
  125. P. Delafontaine and L. Ku, “Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells,” Cardiovascular Research, vol. 33, no. 1, pp. 216–222, 1997. View at Publisher · View at Google Scholar
  126. N. G. Stephens, A. Parsons, P. M. Schofield, F. Kelly, K. Cheeseman, and M. J. Mitchinson, “Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS),” The Lancet, vol. 347, no. 9004, pp. 781–786, 1996. View at Publisher · View at Google Scholar
  127. J.-C. Tardif, G. Côté, J. Lespérance et al., “Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group,” The New England Journal of Medicine, vol. 337, no. 6, pp. 365–372, 1997. View at Publisher · View at Google Scholar
  128. M. Yoshizumi, J.-I. Abe, J. Haendeler, Q. Huang, and B. C. Berk, “Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species,” The Journal of Biological Chemistry, vol. 275, no. 16, pp. 11706–11712, 2000. View at Publisher · View at Google Scholar
  129. Y. Hu, L. Cheng, B.-W. Hochleitner, and Q. Xu, “Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 11, pp. 2808–2816, 1997. View at Google Scholar
  130. S. Kim, Y. Izumi, M. Yano et al., “Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery,” Circulation, vol. 97, no. 17, pp. 1731–1737, 1998. View at Google Scholar
  131. H. Koyama, N. E. Olson, F. F. Dastvan, and M. A. Reidy, “Cell replication in the arterial wall: activation of signaling pathway following in vivo injury,” Circulation Research, vol. 82, no. 6, pp. 713–721, 1998. View at Google Scholar
  132. Y. Izumi, S. Kim, M. Namba et al., “Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery,” Circulation Research, vol. 88, no. 11, pp. 1120–1126, 2001. View at Google Scholar
  133. R. Ricci, G. Sumara, I. Sumara et al., “Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis,” Science, vol. 306, no. 5701, pp. 1558–1561, 2004. View at Publisher · View at Google Scholar · View at PubMed
  134. K. Yoshimura, H. Aoki, Y. Ikeda et al., “Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase,” Nature Medicine, vol. 11, no. 12, pp. 1330–1338, 2005. View at Publisher · View at Google Scholar · View at PubMed
  135. N. Katakami, H. Kaneto, H. Hao et al., “Role of pim-1 in smooth muscle cell proliferation,” The Journal of Biological Chemistry, vol. 279, no. 52, pp. 54742–54749, 2004. View at Publisher · View at Google Scholar · View at PubMed
  136. R. Amaravadi and C. B. Thompson, “The survival kinases Akt and Pim as potential pharmacological targets,” The Journal of Clinical Investigation, vol. 115, no. 10, pp. 2618–2624, 2005. View at Publisher · View at Google Scholar · View at PubMed